SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss centers, Fitness Centers, nursing homes, public health facilities, and retail locations. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1993 and is headquartered in Daejeon, South Korea.
Frequently asked questions
What sector does Hana Must SPAC 2 (208370) operate in?
Hana Must SPAC 2 belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Hana Must SPAC 2 (208370) current stock price?
As of the latest data, Hana Must SPAC 2 stock price is ₩2,335, with a previous close of ₩2,345. Hana Must SPAC 2 lost -₩10 in the last trading session, representing a -0.43% loss.
What is Hana Must SPAC 2 (208370) current market capitalization?
Hana Must SPAC 2 market cap is approximately 60.05 billion.
Does Hana Must SPAC 2 (208370) pay dividends?
No. Hana Must SPAC 2 does not pay a dividend.
What is Hana Must SPAC 2 (208370) beta (volatility) score?
Hana Must SPAC 2 has a beta of -0.707, indicating lower volatility than the overall market.
